Core Insights - AlphaTON Capital Corp is a leading public technology company focused on scaling the Telegram super-app, targeting an addressable market of one billion monthly active users [1][2] - The company provides institutional-grade exposure to the Telegram ecosystem while adhering to Nasdaq governance standards and reporting transparency [2] Company Overview - AlphaTON Capital Corp is incorporated in the British Virgin Islands and trades on Nasdaq under the ticker symbol "ATON" [3] - The company is advancing therapies targeting checkpoint resistance pathways to improve patient quality of life and is involved in drug development and strategic counsel for immunotherapy assets [3] Financial and Share Structure - As of February 19, 2026, AlphaTON has 23,434,588 ordinary shares outstanding [5] - The company has 1,373,686 ordinary shares issuable upon the exercise of outstanding warrants with a weighted average exercise price of $11.62 per share [5] - Additionally, there are 1,283,931 ordinary shares from pre-funded warrants, 316,111 shares from share options under the 2021 Equity Incentive Plan with a weighted average exercise price of $40.65, and 5,410 shares from restricted share units [5]